1. Home
  2. TNXP vs CAN Comparison

TNXP vs CAN Comparison

Compare TNXP & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • CAN
  • Stock Information
  • Founded
  • TNXP 2007
  • CAN 2013
  • Country
  • TNXP United States
  • CAN Singapore
  • Employees
  • TNXP N/A
  • CAN N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • CAN Semiconductors
  • Sector
  • TNXP Health Care
  • CAN Technology
  • Exchange
  • TNXP Nasdaq
  • CAN Nasdaq
  • Market Cap
  • TNXP 335.6M
  • CAN 372.5M
  • IPO Year
  • TNXP N/A
  • CAN 2019
  • Fundamental
  • Price
  • TNXP $22.41
  • CAN $1.28
  • Analyst Decision
  • TNXP Buy
  • CAN Strong Buy
  • Analyst Count
  • TNXP 1
  • CAN 6
  • Target Price
  • TNXP $70.00
  • CAN $2.50
  • AVG Volume (30 Days)
  • TNXP 1.1M
  • CAN 58.5M
  • Earning Date
  • TNXP 11-11-2025
  • CAN 11-19-2025
  • Dividend Yield
  • TNXP N/A
  • CAN N/A
  • EPS Growth
  • TNXP N/A
  • CAN N/A
  • EPS
  • TNXP N/A
  • CAN N/A
  • Revenue
  • TNXP $9,831,000.00
  • CAN $345,360,000.00
  • Revenue This Year
  • TNXP $14.79
  • CAN $78.37
  • Revenue Next Year
  • TNXP $933.49
  • CAN $48.46
  • P/E Ratio
  • TNXP N/A
  • CAN N/A
  • Revenue Growth
  • TNXP N/A
  • CAN 82.40
  • 52 Week Low
  • TNXP $6.76
  • CAN $0.53
  • 52 Week High
  • TNXP $130.00
  • CAN $3.27
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 30.44
  • CAN 74.38
  • Support Level
  • TNXP $23.60
  • CAN $1.22
  • Resistance Level
  • TNXP $29.19
  • CAN $1.57
  • Average True Range (ATR)
  • TNXP 1.63
  • CAN 0.13
  • MACD
  • TNXP 0.12
  • CAN 0.05
  • Stochastic Oscillator
  • TNXP 5.31
  • CAN 68.99

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

Share on Social Networks: